-
Risk for Long-Term Opioid Use Up in Hidradenitis Suppurativa
drugs
September 12, 2019
Patients with hidradenitis suppurativa (HS) have an increased risk for long-term opioid use, according to a study published online in JAMA Dermatology.
-
Opioid Maker Purdue Pharma Expected to File for Bankruptcy
drugs
September 10, 2019
Settlement talks with OxyContin maker Purdue Pharma over its role in the U.S. opioid crisis have reached a stalemate and the company is expected to file for bankruptcy...
-
White House Announces Nearly $2 Billion in Grants to Fight Opioid Epidemic
drugs
September 06, 2019
Nearly $2 billion in grants to help fight the U.S. opioid epidemic will be handed out to states and local governments, the White House says.
-
Purdue Pharma prepares for bankruptcy ahead of opioid crisis trial
europeanpharmaceuticalreview
September 06, 2019
A report has found that the rejection of a settlement offer from Purdue has led to the company arranging to file for bankruptcy.
-
Cesarean Section Quality Initiative Cuts Opioid Use
drugs
September 05, 2019
The enhanced recovery after surgery (ERAS) program, a quality improvement initiative that made changes to preoperative and postoperative processes...
-
U.S. Opioid Prescription Rate Is 7 Times That of Sweden
drugs
September 05, 2019
Amid an epidemic of opioid painkiller addiction, Americans are still being overprescribed narcotic painkillers compared to many other countries, researchers report.
-
Endo and Allergan settle opioid case ahead of trial
europeanpharmaceuticalreview
September 04, 2019
The two pharma companies have agreed to pay $15 million to certain Ohio counties before an opioid abuse trial to be held in October.
-
CDC: January to July 2018 Saw Decrease in Opioid Deaths
drugs
August 30, 2019
Opioid deaths decreased during January to July 2018, while deaths from illicitly manufactured fentanyl (IMF) increased during the same period...
-
J&J ordered to pay $572m to Oklahoma over opioid crisis
europeanpharmaceuticalreview
August 29, 2019
The pharmaceutical company is planning to appeal the decision to pay the state for damages relating to the US opioid crisis.
-
Prenatal Exposure to OMT Does Not Worsen Neonatal Outcomes
drugs
August 28, 2019
Exposure to opioid maintenance treatment (OMT) in the womb does not seem to cause additional harm to newborns, according to a study published online in Pharmacology Research & Perspectives.